Examples of using Enterococcus in English and their translations into Slovenian
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Official/political
-
Programming
Inherently resistant organisms Gram-positive aerobes Enterococcus spp.
Enterococci including Enterococcus faecalis and Enterococcus faecium.
But the drug"Bifiform" includes in its composition also Enterococcus faecium.
Pseudomonas spp., Enterococcus spp, and Bordetella bronchiseptica isolates are inherently resistant to cefovecin.
They contain live lactic acid bacteria of 2 species-Bifidobacterium longum and Enterococcus faecium.
Multidrug-resistant Enterococcus faecalis and Enterococcus faecium are associated with nosocomial infections.
The drug has proven to be effective in combating the main causative agents of cystitis, including staphylococcus,Escherichia coli and enterococcus.
It contains the bacterium Enterococcus faecium, which can have a complex regenerating effect on the intestinal microflora.
The other probiotic strain should prefer the more alkaline and anaerobic conditions of the large intestine-in entiro™ known as Enterococcus mundtii(ST4SA).
Vancomycin-resistant Enterococcus, or vancomycin-resistant enterococci(VRE), are bacterial strains of the genus Enterococcus that are resistant to the antibiotic vancomycin.
Effective against gram-positive and gram-negative bacteria,including Staphylococcus spp., Enterococcus spp., Pseudomonas aeruginosa, E. coli, Streptococcus spp.
Bacteroides, enterococcus, escherichia colie, klebsiella staphylococcus or streptococcus are the most common kinds of bacteria that cause this type of infection.
One capsule contains in its composition live lactic acid bacteria of 2 species-Bifidobacterium longum(10 7 bacterial cells) and Enterococcus faecium(10 7 bacterial cells).
The assessment of the preparation of Enterococcus faecium DSM 10663/NCIMB 10415 shows that the conditions for authorisation, as provided for in Article 5 of Regulation(EC) No 1831/2003, are satisfied.
Elegans has been characterized as a host formultiple human pathogenic bacteria species(i.e., Staphylococcus aureus and Enterococcus faecalis), which can be easily cultured, maintained, and evolved.
Vancomycin-resistant Enterococcus, or vancomycin-resistant enterococci(VRE), are bacterial strains of the genus Enterococcus that are resistant to the antibiotic vancomycin.
At 4 times the minimum inhibitory concentration(MIC),a 2-log reduction in colony counts was observed with tigecycline against Enterococcus spp., Staphylococcus aureus, and Escherichia coli.
Resistance to dalbavancin in Staphylococcus spp. and Enterococcus spp. is mediated by VanA, a genotype that results in modification of the target peptide in nascent cell wall.
There is insufficient evidence to be able to draw any conclusions regarding the possible clinical efficacy of Cubicin against infections due to enterococci, including Enterococcus faecalis and Enterococcus faecium.
The application concerns authorisation of a new use of the preparation of Enterococcus faecium DSM 7134(Bonvital), as a feed additive for piglets(weaned) and pigs for fattening, to be classified in the additive category‘zootechnical additives'.
Yersinia pestis Anaerobic micro-organisms Mobiluncus Other micro-organisms Chlamydia trachomatis($) Chlamydia pneumoniae($) Mycoplasma hominis($) Mycoplasma pneumoniae($) SPECIES FOR WHICH ACQUIRED RESISTANCE MAYBE A PROBLEM Aerobic Gram-positive micro-organisms Enterococcus faecalis($) Staphylococcus spp.*(2) Aerobic Gram-negative micro-organisms Acinetobacter baumannii+ Burkholderia cepacia+* Campylobacter spp.+* Citrobacter freundii* Enterobacter aerogenes Enterobacter cloacae* Escherichia coli* Klebsiella oxytoca Klebsiella pneumoniae* Morganella morganii* Neisseria gonorrhoeae* Proteus mirabilis* Proteus vulgaris* Providencia spp.
Linezolid is effective against all clinically important Gram-positive bacteria- those whose cell wall contains a thick layer of peptidoglycan and no outer membrane- notably Enterococcus faecium and Enterococcus faecalis(including vancomycin-resistant enterococci), Staphylococcus aureus(including methicillin-resistant Staphylococcus aureus, MRSA), Streptococcus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes, the viridans group streptococci, Listeria monocytogenes, and Corynebacterium species(the latter being among the most susceptible to linezolid, with minimum inhibitory concentrations routinely below 0.5 mg/L).
They are effective against enterococci and Escherichia coli.
Tedizolid is bacteriostatic against enterococci, staphylococci, and streptococci in vitro.
This applies to staphylococci, streptococci, enterococci.
There is limited evidence of the clinical efficacy of tigecycline against enterococci.
Numerous pathogens, including Staphylococcus aureus, enterococci, and Streptococcus pyogenes now exhibit resistance worldwide.
Prolonged use may result in the overgrowth of non-susceptible organisms(e.g. enterococci, fungi), which may require interruption of treatment or other appropriate measures.
Other bacteria- enterococci- are resistant to the effects of cephalosporins, despite the fact that these are antibiotics for pyelonephritis with a wide spectrum of action.
Significantly more enterococci and multidrug resistant bacteria were recovered from either the floors or dust of toilets when the jet-air dryers rather than paper towels were in use.